DiI (DiIC18(3)) is a lipid-soluble fluorescent dye that traces neuronal pathways through retrograde and anterograde transport in neurons. It labels cell bodies, axons, dendrites, and dendritic spines, offering high brightness, slow fading, and long-lasting persistence without leakage. It is employed to investigate brain connectivity, including in postmortem human brain tissue.

STL127705 is a potent small molecule inhibitor of Ku70/80 heterodimer protein with an IC50 of 3.5 μM. It disrupts Non-Homologous End-Joining (NHEJ) by preventing DNA binding and inhibiting DNA-PKCS activation. It exhibits anticancer activity by inducing apoptosis and inhibiting cell proliferation.

DiI (DiIC18(3)) is a lipid-soluble fluorescent dye that traces neuronal pathways through retrograde and anterograde transport in neurons. It labels cell bodies, axons, dendrites, and dendritic spines, offering high brightness, slow fading, and long-lasting persistence without leakage. It is employed to investigate brain connectivity, including in postmortem human brain tissue.

DiI (DiIC18(3)) is a lipid-soluble fluorescent dye that traces neuronal pathways through retrograde and anterograde transport in neurons. It labels cell bodies, axons, dendrites, and dendritic spines, offering high brightness, slow fading, and long-lasting persistence without leakage. It is employed to investigate brain connectivity, including in postmortem human brain tissue.

DiI (DiIC18(3)) is a lipid-soluble fluorescent dye that traces neuronal pathways through retrograde and anterograde transport in neurons. It labels cell bodies, axons, dendrites, and dendritic spines, offering high brightness, slow fading, and long-lasting persistence without leakage. It is employed to investigate brain connectivity, including in postmortem human brain tissue.

17-OH PREG (17a-Hydroxypregnenolone) is a pregnenolone metabolite and DHEA precursor. It is formed through CYP17A1 hydroxylase and 17,20-lyase activities. It is the most relevant steroid for the study of elevated plasma levels linked to type II 3β-hydroxysteroid dehydrogenase deficiency.

17-OH PREG (17a-Hydroxypregnenolone) is a pregnenolone metabolite and DHEA precursor. It is formed through CYP17A1 hydroxylase and 17,20-lyase activities. It is the most relevant steroid for the study of elevated plasma levels linked to type II 3β-hydroxysteroid dehydrogenase deficiency.

17-OH PREG (17a-Hydroxypregnenolone) is a pregnenolone metabolite and DHEA precursor. It is formed through CYP17A1 hydroxylase and 17,20-lyase activities. It is the most relevant steroid for the study of elevated plasma levels linked to type II 3β-hydroxysteroid dehydrogenase deficiency.

17-OH PREG (17a-Hydroxypregnenolone) is a pregnenolone metabolite and DHEA precursor. It is formed through CYP17A1 hydroxylase and 17,20-lyase activities. It is the most relevant steroid for the study of elevated plasma levels linked to type II 3β-hydroxysteroid dehydrogenase deficiency.

OPN Expression Inhibitor 1 (Compound 11) is a DHA ether derivative containing a 1,2,3-triazole ring that effectively inhibits osteopontin (OPN) expression. It exhibits significant potential as an anticancer agent by specifically targeting OPN, a key factor in breast cancer progression and metastasis.